Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial)

BACKGROUND: At present, women with threatened preterm labor before 32 weeks of gestation are, after transfer to a perinatal center, treated with tocolytics and corticosteroids. Many of these women are treated unnecessarily. Fibronectin is an accurate predictor for the occurrence of preterm birth amo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vis, Jolande Y, Wilms, Femke F, Oudijk, Martijn A, Porath, Martina M, Scheepers, Hubertina CJ, Bloemenkamp, Kitty WM, Bolte, Annemiek C, Cornette, Jérôme, Derks, Jan B, Duvekot, Johannes J, van Eyck, Jim, Kwee, Anneke, Opmeer, Brent C, van Pampus, Maria G, Lotgering, Fred K, Scherjon, Sicco A, Sollie, Krystyna M, Spaanderman, Marc EA, Willekes, Christine, van der Post, Joris AM, Mol, Ben Willem J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752451/
https://www.ncbi.nlm.nih.gov/pubmed/19723320
http://dx.doi.org/10.1186/1471-2393-9-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752451/
https://www.ncbi.nlm.nih.gov/pubmed/19723320
http://dx.doi.org/10.1186/1471-2393-9-38

Ejemplares similares